Results 211 to 220 of about 852,668 (314)
Nontumoral portal vein thrombosis in patients awaiting liver transplantation
Hui Chen +9 more
semanticscholar +1 more source
Vat photopolymerization‐based bioprinting: Shaping next‐generation tissues with light
Vat photopolymerization‐based bioprinting is revolutionizing biofabrication by enabling high‐precision construction of biological structures. This review systematically examines photopolymerization mechanisms and variants in printing techniques, discusses design principles and composition of bio‐inks, and highlights recent progress toward next ...
Wei Long Ng +4 more
wiley +1 more source
Massive haematemesis as the first manifestation of superior mesenteric and portal vein thrombosis in a healthy young adult. [PDF]
Yasin S +4 more
europepmc +1 more source
Napabucasin reduces liver metastases by reprogramming the hepatic microenvironment. It induces hepatocyte secretion of CCL21 via c‐Fos activation, recruiting lymphocytes and converting “cold” metastases into immunologically “hot” tumors. This effect is liver‐specific and independent of cancer cells.
Qiongqiong Wang +19 more
wiley +1 more source
Natural course of portal vein aneurysm - does morphology matter? [PDF]
Kurtcehajic A +5 more
europepmc +1 more source
A Comparative Study of Ultrasonography and CT Venography in the Diagnosis of Budd‐Chiari Syndrome
Budd‐Chiari syndrome (BCS) is characterized by hepatic venous outflow obstruction from the hepatic veins to the junction of the inferior vena cava (IVC) and right atrium. Ultrasound (US) and CT venography (CTV) are used as imaging techniques for the diagnosis of BCS, and We compared the diagnostic efficacy of the two modalities. The results showed that
Tiling Jiang +6 more
wiley +1 more source
Microwave ablation and portal vein embolization for staged hepatectomy. [PDF]
Simbeck A, Reese T, Oldhafer KJ.
europepmc +1 more source
Noncirrhotic Portal Hypertension – A Case Report on a Sequela of Portal Vein Cavernoma
ISAAC MAWUNYEGA KWAKU AHORKLO +2 more
openalex +2 more sources
ABSTRACT Purpose To evaluate the safety and efficacy of neoadjuvant gemcitabine, cisplatin, and S‐1 (GCS) chemotherapy for resectable biliary tract cancer (BTC) and FDG‐PET‐positive lymph nodes in a multicenter phase II study (KHBO1201). Methods Patients with resectable BTC (intrahepatic/extrahepatic bile duct, gallbladder, or ampullary cancers) and ...
Satoshi Ogiso +9 more
wiley +1 more source

